| Drug Class: |
Growth Hormone-Releasing Hormone (GHRH) analog peptide |
| Molecular Formula: |
C221H366N72O67S |
| Molecular Weight: |
~5135.9 Da |
| Form: |
Lyophilized peptide for injection (vial) |
| Purity: |
Not specified (research/pharmaceutical-grade peptide synthesis) |
| Sequence: |
Synthetic 44-amino-acid analogue of human Growth Hormone-Releasing Hormone (GHRH) with a trans-3-hexenoic acid modification at the N-terminus |
| Brand: |
Axiolabs |
| Substances: |
Tesamorelin Acetate |
| Concentration: |
5 mg |
Product Disclaimer: Research Purposes Only
This product is intended strictly for laboratory research and in vitro analysis. It is not approved for human or animal use. Any form of internal administration is prohibited by law. Handling should be limited to qualified and licensed professionals. This item is not classified as a pharmaceutical, dietary supplement, or cosmetic product. For educational and scientific research use only.
Tesamorelin 5mg – GHRH Analog Research Peptide by Axiolabs
Introduction and Overview
Tesamorelin is a synthetic peptide classified as a growth hormone-releasing hormone (GHRH) analog, investigated in laboratory and preclinical research for its interaction with pituitary signaling pathways and endocrine regulatory networks. Structurally designed to mimic endogenous GHRH activity, Tesamorelin is used in experimental systems examining hypothalamic-pituitary communication and peptide-mediated hormone signaling.
Research involving Tesamorelin focuses on receptor binding behavior, intracellular signaling cascades, and endocrine feedback mechanisms associated with growth hormone regulation. Studies are conducted in controlled environments to better understand molecular signaling rather than physiological or clinical outcomes.
This compound is strictly intended for research purposes only and is not approved for human consumption, therapeutic application, or diagnostic use.
Biological Relevance
GHRH Receptor Signaling Pathways
Tesamorelin is studied for its interaction with the growth hormone-releasing hormone receptor (GHRH-R), a G protein-coupled receptor expressed primarily in pituitary somatotroph cells. Activation of this receptor initiates intracellular signaling networks including:
- cAMP/PKA signaling – associated with transcriptional activation and hormonal regulation
- MAPK/ERK pathways – involved in cellular signaling integration
- CREB phosphorylation pathways – linked to gene expression regulation
- Calcium-dependent signaling cascades – associated with endocrine secretion mechanisms
These pathways are analyzed in laboratory models to understand peptide-mediated regulation of endocrine signaling systems.
Hypothalamic-Pituitary Axis Research
Tesamorelin is widely studied within models of the hypothalamic-pituitary axis (HPA axis), a central neuroendocrine system responsible for hormone regulation and intercellular communication. Researchers investigate how GHRH analogs influence:
- Pituitary somatotroph activity
- Hormonal feedback loops
- Neuroendocrine signaling integration
- Receptor sensitivity modulation
This research is closely associated with endocrine research and neurocognitive research.
Metabolic Signaling and Cellular Regulation
Experimental studies involving Tesamorelin often explore metabolic signaling pathways associated with nutrient sensing, mitochondrial communication, and intracellular energy regulation systems. Key pathways include:
- AMPK signaling – energy homeostasis regulation
- mTOR pathways – protein synthesis and growth signaling
- IGF-related signaling cascades – downstream endocrine communication networks
These investigations are commonly linked to metabolic research and longevity research.
Research Applications and Experimental Investigation
Endocrine Receptor Binding Studies
Tesamorelin is used in receptor-binding assays to evaluate affinity, selectivity, and activation patterns of GHRH receptors in controlled laboratory environments.
Signal Transduction and Hormonal Pathway Mapping
Researchers investigate intracellular signaling cascades triggered by GHRH receptor activation, focusing on second messenger systems such as cAMP and downstream transcriptional regulators.
Neuroendocrine Communication Models
Laboratory systems involving Tesamorelin examine interactions between hypothalamic signaling pathways and pituitary hormone regulation networks.
Internal and External Research Connections
Tesamorelin-related research intersects with multiple biomedical disciplines. In cardiovascular research, endocrine signaling pathways are studied in relation to vascular regulation and cellular communication systems. In inflammation research, researchers examine how hormonal signaling interacts with cytokine-mediated pathways.
Additional overlap exists with musculoskeletal research, where endocrine signaling influences structural tissue communication systems, and immune support research, which investigates hormonal modulation of immune signaling pathways.
Researchers commonly access peer-reviewed literature via PubMed, the NCBI database, and publications from the National Institutes of Health.
Product Information
Compound Details
- Product Title: Tesamorelin
- Active Substance: Tesamorelin
- Concentration: 5mg
- Pack Size: Vial
- Manufacturer: Axiolabs
Compliance and Disclaimer
Tesamorelin is strictly intended for laboratory and preclinical research purposes only. It is not approved for human consumption, medical treatment, or diagnostic use by regulatory authorities including the U.S. Food and Drug Administration.
No claims regarding safety, efficacy, or clinical outcomes are made or implied. All handling and study of peptide compounds must comply with institutional biosafety standards, ethical research protocols, and applicable regulatory requirements.
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic GHRH analog studied in laboratory settings for its interaction with growth hormone-releasing hormone receptor signaling pathways.
Which pathways are commonly studied with Tesamorelin?
Research focuses on cAMP/PKA signaling, MAPK/ERK cascades, CREB activation, and neuroendocrine hormone regulation systems.
Is Tesamorelin approved for human use in this context?
No. Tesamorelin referenced here is strictly for research purposes only and is not approved for therapeutic or clinical applications.
Which scientific disciplines study GHRH analogs?
Relevant fields include endocrine research, metabolic research, neurocognitive research, and longevity research.
Where can scientific literature on GHRH signaling be accessed?
Peer-reviewed sources are available through PubMed, NCBI, and institutional research publications from the NIH.
References
PubMed – Tesamorelin and GHRH Signaling Research
NCBI – Hypothalamic-Pituitary Axis and Endocrine Regulation
NCBI – Cellular Signal Transduction Mechanisms
NIH – Endocrine and Hormonal Research Resources
FDA – Regulatory Guidance for Research Compounds
WHO – Biomedical Research and Laboratory Standards
Tesamorelin – FAQ
✔️ What is Tesamorelin?
Tesamorelin is a Growth Hormone Releasing Hormone (GHRH) analog studied for its ability to stimulate natural HGH production and influence fat metabolism regulation.
✔️ How does Tesamorelin work?
It activates the pituitary gland to increase secretion of Human Growth Hormone (HGH), which indirectly supports IGF-1 production and metabolic activity.
✔️ What is Tesamorelin primarily studied for?
It is most commonly researched for its effects on visceral fat reduction, metabolic improvement, and body composition regulation.
✔️ How is Tesamorelin different from HGH?
Unlike direct HGH administration, Tesamorelin stimulates the body to produce its own natural growth hormone pulses, making it a secretagogue rather than a replacement hormone.
✔️ How should Tesamorelin be stored?
Store the Tesamorelin vial in a refrigerator at 2–8°C (36–46°F) and protect it from heat, light, and moisture to maintain peptide stability and potency.
✔️ What happens after reconstitution?
After mixing with sterile bacteriostatic water, it should be refrigerated and used within the recommended usage period to preserve effectiveness.
✔️ Is Tesamorelin used in medical research?
Yes, it has been studied in clinical settings for metabolic disorders, particularly in relation to abdominal fat accumulation and growth hormone deficiency contexts.
✔️ Can Tesamorelin help with fat loss research?
Studies suggest it may reduce visceral adipose tissue (deep abdominal fat) by improving lipid metabolism and hormonal balance.
✔️ Does Tesamorelin affect muscle growth?
Indirectly, increased HGH and IGF-1 levels may support lean body mass preservation and recovery, depending on research context.
✔️ Is Tesamorelin safe?
Tesamorelin is a research and prescription-only compound in certain regions, and should be used responsibly under a controlled environment or professional supervision.
✔️ Are there side effects of Tesamorelin?
Possible effects include injection site reactions, mild water retention, headache, or temporary joint discomfort.
✔️ Where can I buy authentic Tesamorelin?
Always purchase from trusted sources such as verified peptide suppliers or reputable research chemical distributors to ensure authenticity, purity, and safety standards.
Tesamorelin – Storage & Safety Guidelines
Preserve Growth Hormone–Releasing Stability
To maintain the full biological activity of Tesamorelin, store the vial in a cool, dry, and dark environment, protected from direct sunlight, heat exposure, and humidity fluctuations. Before reconstitution, stable room-temperature storage is acceptable under controlled conditions. Once prepared, the solution must be kept refrigerated at 2–8°C (36–46°F) to preserve peptide integrity, receptor stimulation capacity, and molecular stability. Avoid repeated freeze–thaw cycles, as they can significantly reduce potency and functional performance.
Safe Handling & Preparation Protocols
Always handle Tesamorelin peptide using sterile syringes, alcohol swabs, and disposable gloves to prevent microbial contamination. Do not use the solution if it appears cloudy, discolored, or contains visible particles. Follow strictly recommended usage guidelines and seek supervision from a qualified healthcare professional when necessary. Keep the vial securely stored away from children and pets, and ensure proper medical-grade disposal of any unused material.
Best Practices for Stability & Longevity
- Always verify the expiration date before use to ensure product safety and reliability.
- Store in the original vial and packaging to reduce exposure to light-induced degradation and oxidation.
- Handle gently—avoid shaking to preserve peptide structure and receptor-binding efficiency.
Why Proper Storage Matters
Correct storage and safety practices ensure that Tesamorelin maintains its full growth hormone–releasing and metabolic regulation activity. Following these guidelines helps preserve compound stability, dosing accuracy, and user safety, ensuring consistent performance from every vial of this advanced GHRH analog peptide therapy compound.